论文部分内容阅读
目的:探讨急性脑血管治疗中,应用血压调治系统技术的临床效果。方法:2658例患者随机配对分为治疗组和对照组各1329例。两组常规治疗一致,对照组血压习惯治疗,治疗组将血压个体化的分成三个类型,采取应对措施,调治在目标血压范围内,并维持一周。在10天、30天分别进行评定。结果:治疗组治愈率和总有效率在10天、30天分别为32.73%和74.19%、96.01%和98.12%,极明显高于对照组;治疗组死亡率在10天、30天分别为0.30%和0.45%,极明显低于对照组,治疗组与对照组比较均有极明显差异(P<0.001)。结论:急性脑血管病血压调治系统技术显示了目标血压的恒定性,达到了极其显著的临床疗效。
Objective: To investigate the clinical effect of blood pressure control system in acute cerebrovascular disease. Methods: A total of 2658 patients were randomly assigned to treatment group and control group of 1329 cases. Two groups of conventional treatment consistent with the control group of blood pressure treatment, the treatment group will be divided into three types of individualized blood pressure, take countermeasures, treatment in the target blood pressure range, and maintain a week. In 10 days, 30 days were assessed. Results: The cure rate and total effective rate in the treatment group were 32.73% and 74.19%, 96.01% and 98.12% on the 10th and 30th days, respectively, which were significantly higher than those in the control group. The mortality rates in the treatment group were 0.30 % And 0.45%, respectively, significantly lower than the control group, the treatment group and the control group were significantly different (P <0.001). Conclusion: Acute cerebrovascular disease blood pressure regulating system technology shows the target blood pressure is constant, reaching a very significant clinical effect.